Drug Type Protein drugs |
Synonyms- |
Target |
Mechanism NRG1 modulators(Neuregulin-1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder, Major | Preclinical | KR | 02 Jan 2024 | |
Depressive Disorder, Major | Preclinical | US | 02 Jan 2024 | |
Stress Disorders, Post-Traumatic | Preclinical | US | 02 Jan 2024 | |
Stress Disorders, Post-Traumatic | Preclinical | KR | 02 Jan 2024 |